PRELUDE CAPITAL MANAGEMENT, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 159 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,000
-99.5%
200
-99.1%
0.00%
-100.0%
Q2 2019$194,000
-65.1%
23,328
-58.3%
0.01%
-67.7%
Q1 2019$556,000
+134.6%
55,906
+80.1%
0.03%
+93.8%
Q4 2018$237,000
+717.2%
31,034
+1792.3%
0.02%
+700.0%
Q3 2018$29,000
-96.2%
1,640
-97.9%
0.00%
-95.8%
Q2 2018$755,00079,5120.05%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 622,249$10,360,4463.42%
GREAT POINT PARTNERS LLC 1,000,000$16,650,0003.27%
Ghost Tree Capital, LLC 600,000$9,990,0002.95%
SILVERARC CAPITAL MANAGEMENT, LLC 380,000$6,327,0002.61%
Integral Health Asset Management, LLC 727,100$12,106,2152.44%
Sio Capital Management, LLC 250,000$4,162,5002.06%
Boxer Capital, LLC 2,000,000$33,3001.64%
DAFNA Capital Management LLC 319,155$5,313,9311.59%
5AM Venture Management, LLC 350,000$5,827,5001.49%
Monashee Investment Management LLC 300,000$4,995,0001.38%
View complete list of VIKING THERAPEUTICS INC shareholders